A Study to Evaluate Efficacy and Safety of GW117 Tablets in Major Depressive Disorder

NCT06796868 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: GW117 Tablets
DRUG: GW117 Tablets
DRUG: GW117 Tablets
DRUG: Placebo

Sponsor

Beijing Greatway Pharmaceutical Technology Co.,Ltd.